Literature DB >> 5250184

Rubella vaccination in adult females.

R E Weibel, J Stokes, E B Buynak, M R Hilleman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5250184     DOI: 10.1056/NEJM196903272801302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Authors:  Selidji T Agnandji; Angela Huttner; Madeleine E Zinser; Patricia Njuguna; Christine Dahlke; José F Fernandes; Sabine Yerly; Julie-Anne Dayer; Verena Kraehling; Rahel Kasonta; Akim A Adegnika; Marcus Altfeld; Floriane Auderset; Emmanuel B Bache; Nadine Biedenkopf; Saskia Borregaard; Jessica S Brosnahan; Rebekah Burrow; Christophe Combescure; Jules Desmeules; Markus Eickmann; Sarah K Fehling; Axel Finckh; Ana Rita Goncalves; Martin P Grobusch; Jay Hooper; Alen Jambrecina; Anita L Kabwende; Gürkan Kaya; Domtila Kimani; Bertrand Lell; Barbara Lemaître; Ansgar W Lohse; Marguerite Massinga-Loembe; Alain Matthey; Benjamin Mordmüller; Anne Nolting; Caroline Ogwang; Michael Ramharter; Jonas Schmidt-Chanasit; Stefan Schmiedel; Peter Silvera; Felix R Stahl; Henry M Staines; Thomas Strecker; Hans C Stubbe; Benjamin Tsofa; Sherif Zaki; Patricia Fast; Vasee Moorthy; Laurent Kaiser; Sanjeev Krishna; Stephan Becker; Marie-Paule Kieny; Philip Bejon; Peter G Kremsner; Marylyn M Addo; Claire-Anne Siegrist
Journal:  N Engl J Med       Date:  2015-04-01       Impact factor: 91.245

2.  New Japanese rubella vaccine: comparative trials.

Authors:  J M Best; J E Banatvala; J M Bowen
Journal:  Br Med J       Date:  1974-07-27

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

Review 4.  Immunization today--a review.

Authors:  M I Marks; M Brazeau; R M Shapera
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

5.  Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Authors:  M Lalla; T Vesikari; M Virolainen
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

6.  A study of rubella haemagglutination inhibition antibodies in rheumatoid arthritis.

Authors:  J N Kacaki; P C Balduzzi; J H Vaughan
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

7.  Reactive arthritis.

Authors:  C R Hind
Journal:  Postgrad Med J       Date:  1982-03       Impact factor: 2.401

8.  Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis.

Authors:  C A Mims; A Stokes; R Grahame
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

9.  Adult-onset Still's disease.

Authors:  M Harth; J M Thompson; E D Ralph
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

10.  Rheumatoid polyarthritis after rubella.

Authors:  J N McCormick; J J Duthie; H Gerber; H Hart; S Baker; B P Marmion
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.